Hjem › Myelodysplastiske syndromer › Missouri › Kansas City
Kliniske studier for Myelodysplastiske syndromer i Kansas City, MO
7 studier for Myelodysplastiske syndromer søker deltakere på steder i og rundt Kansas City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
- University Health Truman Medical Center, Kansas City
- University of Kansas Cancer Center - Briarcliff, Kansas City
- University of Kansas Cancer Center - North, Kansas City
- og 1 flere
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi unna
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
RekruttererFase 3
- American Oncology Partners P.A. MidAmerica Cancer Care, Kansas City
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Children's Mercy Hospitals and Clinics, Kansas City
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
RekruttererFase 3
- MidAmerica Cancer Care, Kansas City
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
RekruttererFase 1
- University of Kansas Cancer Center, Westwood · 5 mi unna
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Kansas City
Myelodysplastiske syndromer-studier i andre byer
- Houston, TX43 studier
- Baldwin Park, CA26 studier
- New York City, NY21 studier
- Seattle, WA21 studier
- Washington, DC20 studier
- Tampa, FL19 studier
- Boston, MA19 studier
- Miami, FL17 studier
- Durham, NC14 studier
- Columbus, OH14 studier
- St. Louis, MO13 studier
- Atlanta, GA13 studier
Andre studier i Kansas City
- Brystkreft34 studier
- Ikke-småcellet lungekreft31 studier
- Hjertesvikt25 studier
- Kreft (alle typer)21 studier
- Lungekreft19 studier
- Kolorektal kreft16 studier
- Metastatisk kreft15 studier
- Akut myelogen leukemi15 studier
- Prostatakreft14 studier
- Eggstokkreft11 studier
- Fedme11 studier
- Type 2-diabetes11 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.